Dr Edward S Pereira, MD | |
3550 University Blvd S, Suite 302, Jacksonville, FL 32216-4246 | |
(904) 733-4444 | |
Not Available |
Full Name | Dr Edward S Pereira |
---|---|
Gender | Male |
Speciality | Peripheral Vascular Disease |
Experience | 30 Years |
Location | 3550 University Blvd S, Jacksonville, Florida |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1013922749 | NPI | - | NPPES |
30173 | Other | FL | BCBS |
274080000 | Medicaid | FL | |
P00275053 | Other | FL | RAILROAD MEDICARE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RC0000X | Internal Medicine - Cardiovascular Disease | ME 94160 (Florida) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Flagler Hospital | Saint augustine, FL | Hospital |
Memorial Hospital Jacksonville | Jacksonville, FL | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Drs Baker And Gilmour Md Pa | 5193622058 | 5 |
News Archive
Children's Hospital Colorado has announced that its Mike McMorris Cystic Fibrosis Research and Care Center, one of the largest cystic fibrosis clinical care centers in the U.S., is participating in one of two Phase Three clinical trials related to the development of a possible breakthrough therapy for people with CF.
Critical Outcome Technologies Inc. announced today that the Company was selected by the Consulate General of Canada and BIOTECanada to attend a life sciences partnering mission in Boston, MA. This initiative is being held in conjunction with the BioPharm America conference taking place September 15-17, 2010.
CIGNA Corporation today reported shareholders' net income of $329 million, or $1.19 per share, for the third quarter of 2009 compared with shareholders' net income of $171 million, or $0.62 per share, for the same period last year. Shareholders' net income for the third quarter 2009 included income related to the variable annuity products within our Run-off Reinsurance segment of $16 million after-tax, or $0.06 per share, primarily related to favorable performance in the equity markets.
Men enrolled in the Prostate, Lung, Colorectal and Ovarian Cancer (PLCO) Screening Trial had no evidence of a mortality benefit compared to a control group of men undergoing usual care, according to a study published online Jan. 6 in the Journal of the National Cancer Institute.
According to Queensland Premier Anna Bligh, new developments are on the horizon only if her Government continues with the sell off of $15 billion of public assets. She revealed this in her annual State of the State address at the mid point of her term in Government yesterday while reviewing the past 18 months and forecasting the next stage of the state's development.
› Verified 9 days ago
Entity Name | Drs Baker & Gilmour Md Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1962555490 PECOS PAC ID: 5193622058 Enrollment ID: O20031217001068 |
News Archive
Children's Hospital Colorado has announced that its Mike McMorris Cystic Fibrosis Research and Care Center, one of the largest cystic fibrosis clinical care centers in the U.S., is participating in one of two Phase Three clinical trials related to the development of a possible breakthrough therapy for people with CF.
Critical Outcome Technologies Inc. announced today that the Company was selected by the Consulate General of Canada and BIOTECanada to attend a life sciences partnering mission in Boston, MA. This initiative is being held in conjunction with the BioPharm America conference taking place September 15-17, 2010.
CIGNA Corporation today reported shareholders' net income of $329 million, or $1.19 per share, for the third quarter of 2009 compared with shareholders' net income of $171 million, or $0.62 per share, for the same period last year. Shareholders' net income for the third quarter 2009 included income related to the variable annuity products within our Run-off Reinsurance segment of $16 million after-tax, or $0.06 per share, primarily related to favorable performance in the equity markets.
Men enrolled in the Prostate, Lung, Colorectal and Ovarian Cancer (PLCO) Screening Trial had no evidence of a mortality benefit compared to a control group of men undergoing usual care, according to a study published online Jan. 6 in the Journal of the National Cancer Institute.
According to Queensland Premier Anna Bligh, new developments are on the horizon only if her Government continues with the sell off of $15 billion of public assets. She revealed this in her annual State of the State address at the mid point of her term in Government yesterday while reviewing the past 18 months and forecasting the next stage of the state's development.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Edward S Pereira, MD 3550 University Blvd S, Suite 302, Jacksonville, FL 32216-4246 Ph: (904) 733-4444 | Dr Edward S Pereira, MD 3550 University Blvd S, Suite 302, Jacksonville, FL 32216-4246 Ph: (904) 733-4444 |
News Archive
Children's Hospital Colorado has announced that its Mike McMorris Cystic Fibrosis Research and Care Center, one of the largest cystic fibrosis clinical care centers in the U.S., is participating in one of two Phase Three clinical trials related to the development of a possible breakthrough therapy for people with CF.
Critical Outcome Technologies Inc. announced today that the Company was selected by the Consulate General of Canada and BIOTECanada to attend a life sciences partnering mission in Boston, MA. This initiative is being held in conjunction with the BioPharm America conference taking place September 15-17, 2010.
CIGNA Corporation today reported shareholders' net income of $329 million, or $1.19 per share, for the third quarter of 2009 compared with shareholders' net income of $171 million, or $0.62 per share, for the same period last year. Shareholders' net income for the third quarter 2009 included income related to the variable annuity products within our Run-off Reinsurance segment of $16 million after-tax, or $0.06 per share, primarily related to favorable performance in the equity markets.
Men enrolled in the Prostate, Lung, Colorectal and Ovarian Cancer (PLCO) Screening Trial had no evidence of a mortality benefit compared to a control group of men undergoing usual care, according to a study published online Jan. 6 in the Journal of the National Cancer Institute.
According to Queensland Premier Anna Bligh, new developments are on the horizon only if her Government continues with the sell off of $15 billion of public assets. She revealed this in her annual State of the State address at the mid point of her term in Government yesterday while reviewing the past 18 months and forecasting the next stage of the state's development.
› Verified 9 days ago
Dr. Jami Ann Rothe Kinnucan, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 4500 San Pablo Rd S, Jacksonville, FL 32224 Phone: 904-953-2000 | |
Michelle Tulang, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 4500 San Pablo Rd S, Jacksonville, FL 32224 Phone: 904-953-2000 | |
Dr. Minnsun Koh Park, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 3900 University Blvd S, Jacksonville, FL 32216 Phone: 904-222-6656 | |
Sandrela Mussallam Abu Shaibeh, Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 820 Prudential Dr Ste 304, Jacksonville, FL 32207 Phone: 904-202-3860 Fax: 904-202-3846 | |
Krunal Patel, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 4800 Belfort Rd, Jacksonville, FL 32256 Phone: 904-398-7205 Fax: 904-396-4047 | |
Zaid Abdel Rahman, M.D. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 4500 San Pablo Rd S, Jacksonville, FL 32224 Phone: 904-953-2000 | |
Sina O'sullivan, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 4500 San Pablo Rd S, Jacksonville, FL 32224 Phone: 904-953-2000 |